NR2F1 and neoplasm: Moreover, elevated levels of NR2F1-AS1 are significantly correlated with adverse outcomes, including poor overall survival, advanced TNM staging, larger tumor size, increased metastatic potential, recurrence risk, and resistance to therapy.